2026-01-04 - Analysis Report
Okay, let's break down the analysis of Salesforce (CRM) based on the provided data.

**1) Return Rate Comparison:**

*   **Company Overview:** Salesforce Inc. is a cloud-based software company providing customer relationship management (CRM) services.
*   **CRM Cumulative Return:** -10.62%
*   **S&P 500 (VOO) Cumulative Return:** 91.00%
*   **Divergence:**  -101.6 (Relative Divergence: 6.0)

**Analysis:**  Salesforce has significantly underperformed the S&P 500 over the period examined. The negative divergence of -101.6 indicates a substantial difference in cumulative returns. The relative divergence of 6.0 suggests that the current divergence is near the lower end of its historical range (min to max).

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
|------------|--------|--------|---------|--------|--------|
| 2016-2018  | 21.0%  | 29.8%  | 17.0%   | 1.4    | 130.4  |
| 2017-2019  | 15.0%  | 29.8%  | -2.0%   | 1.4    | 154.8  |
| 2018-2020  | 9.0%   | 29.8%  | -11.0%  | 1.1    | 211.8  |
| 2019-2021  | 33.0%  | 21.2%  | -10.0%  | 1.1    | 241.9  |
| 2020-2022  | -73.0% | 59.8%  | -71.0%  | 1.2    | 126.2  |
| 2021-2023  | -42.0% | 59.8%  | -43.0%  | 1.4    | 250.5  |
| 2022-2024  | -37.0% | 52.3%  | -56.0%  | 1.4    | 318.3  |
| 2023-2025  | 10.0%  | 32.1%  | -52.0%  | 1.2    | 252.2  |

*   **CAGR (Compound Annual Growth Rate):**  Growth has been volatile, with significant negative CAGR in recent periods.
*   **MDD (Maximum Drawdown):**  Indicates significant potential loss from peak to trough.  High MDD in 2020-2023 and 2021-2023.
*   **Alpha:**  Consistently negative in recent periods, meaning the stock has underperformed its benchmark on a risk-adjusted basis.  This is a major concern.
*   **Beta:**  Fluctuates around 1, indicating that CRM's volatility is similar to the market.
*   **Cap(B):**  Market capitalization, showing growth and then decline with stock performance.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 253.62
*   **Previous Close:** 264.91
*   **Change:** -4.26
*   **5-day SMA:** 263.35
*   **20-day SMA:** 260.64
*   **60-day SMA:** 249.29

**Analysis:** The current price is below the 5-day and 20-day SMAs, suggesting a short-term downward trend.  The price is currently above the 60-day SMA, indicating a possible longer-term support level. The negative change from the previous close indicates recent selling pressure.

**3) RSI, PPO and Hybrid Signal:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 37.53 (Approaching oversold, but not there yet)
*   **PPO:** -0.25 (Slightly negative, suggesting bearish momentum)
*   **Hybrid Signal:**  cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.80) - A buy signal with safety considerations, likely due to the medium MRI.
*   **Recent (20 days) relative divergence change:** -0.9 (Short-term decline)
*   **Expected Return (%):** -749.7 (Extremely negative expected return compared to S&P 500).

**Analysis:**  The RSI suggests that the stock is approaching oversold territory, which could lead to a potential bounce. However, the PPO indicates bearish momentum.  The "safe" buy signal is likely generated by the MRI indicating medium risk, but the extremely negative expected return raises serious concerns.

**4) Recent News & Significant Events:**

*   **Salesforce (CRM) Stock Trades Down:**  Confirms the recent price decline.
*   **Benioffâ€™s MrBeast Super Bowl pitch keeps CRM in focus:** Indicates marketing and promotion efforts.
*   **Salesforce.com (CRM) Stock Dips While Market Gains:** Highlights underperformance relative to the market.
*   **3 Big Rebound Stocks for 2026:** Suggests potential for future recovery.
*   **Salesforce Insiders Sell US$8.1m Of Stock, Possibly Signalling Caution:** Insider selling is generally viewed negatively.
*   **Salesforce (CRM) Earnings Beat Highlights Expanding AI Adoption:** A positive, indicating progress with newer technologies.

**Analysis:**  The news is mixed.  While the earnings beat and AI adoption are positive, the stock price decline, underperformance against the market, and insider selling raise red flags.

**4-2) Analyst Opinions:**

*   **Consensus:** Neutral (no specific key or mean provided)
*   **Opinions:** 53
*   **Target Price (avg/high/low):** 330.06 / 475.00 / 223.00
*   **Recent Rating Changes:** No change information provided.

**Analysis:** Analysts, on average, are cautiously optimistic, as the average target price is higher than the current price.  However, the wide range between high and low target prices suggests considerable uncertainty.

**5) Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|--------------|
| 2025-12-04 | 2.2  | 10.26 B$     |
| 2025-09-04 | 1.97 | 10.24 B$     |
| 2025-05-29 | 1.61 | 9.83 B$      |
| 2024-12-04 | 1.6  | 9.44 B$      |
| 2025-12-04 | 1.6  | 9.44 B$     |

**Analysis:** Both EPS and Revenue have generally been increasing over the past few quarters, demonstrating growth in earnings.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|---------------|-------------|---------------|
| 2025-10-31 | $10.26B  | 78.02%        |
| 2025-07-31 | $10.24B  | 78.10%        |
| 2025-04-30 | $9.83B   | 76.96%        |
| 2025-01-31 | $9.99B   | 77.81%        |
| 2024-10-31 | $9.44B   | 77.71%        |

**Analysis:** Revenue is increasing, and the profit margin is consistently high, indicating strong operational efficiency.

**Capital and Profitability:**

| Quarter      | Equity     | ROE     |
|---------------|--------------|----------|
| 2025-10-31 | $60.02B   | 3.48%    |
| 2025-07-31 | $61.33B   | 3.08%    |
| 2025-04-30 | $60.67B   | 2.54%    |
| 2025-01-31 | $61.17B   | 2.79%    |
| 2024-10-31 | $58.52B   | 2.61%    |

**Analysis:** Equity is relatively stable. The Return on Equity (ROE) is positive and fluctuating, suggesting the company is generating profit from shareholders' investments, although the ROE is not exceptionally high.

**7) Comprehensive Analysis:**

Salesforce's recent performance is concerning. While revenue and earnings have been growing, the stock has significantly underperformed the S&P 500. The negative Alpha, insider selling, and negative expected return all point to potential risks. Analyst opinions are cautiously optimistic. While the technical indicators show the stock approaching oversold levels, overall the current market data points towards caution when investing in Salesforce. The company's core fundamentals appear solid, and recent headlines show a focus on AI, which is promising, however, there may be underlying factors causing the poor investment performance.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.